Chief Medical Officer (CMO)

About Us : Artera is a leading precision medicine company developing AI tests to personalize cancer therapy. Artera offers an AI-enabled test that is the first of its kind to provide both predictive and prognostic results for patients with localized prostate cancer: ArteraAI Prostate Test.

Artera’s multimodal artificial intelligence (MMAI) biomarker test leverages a unique algorithm that assesses digital images from a patient’s biopsy and learns from a patient’s clinical data. The ArteraAI test combines this information to determine prognosis and predict whether a patient will benefit from a particular therapy. The test has been validated using many Phase 3 randomized trials yielding level 1B evidence and inclusion within the NCCN guidelines.

The Chief Medical Officer (CMO) is a core member of the executive leadership team and the primary medical spokesperson for the company. This company leader is responsible for setting and communicating the medical vision for where the company should go by identifying the most important unmet clinical needs and ensuring that these align with business impact. The CMO will shape the company’s clinical strategy, build a strong pipeline of high-quality data and strategic collaborators, communicate with key opinion leaders, and guide the organization toward innovations that will make a measurable difference for cancer patients. The CMO must be a highly credible and influential voice within the cancer community, with trusted relationships among leading oncologists and KOLs that can accelerate adoption and shape standards of care.

This role requires a practicing or former oncologist (radiation oncologist or medical oncologist) who deeply understands what will be clinically impactful and can translate that insight into company direction. The defining quality of a strong CMO is their ability to craft a medical strategy and lead strong teams to execute the strategy.